First prospective RCT comparing arthroscopic rotator cuff repair with vs. without concentrated bone marrow aspirate (cBMA) augmentation in patients with isolated 1–3 cm supraspinatus tears. Assesses patient-reported outcomes over 2 years and structural integrity on 1-year MRI using Sugaya classification.
When counseling patients on cBMA augmentation for small-to-medium rotator cuff repairs, recognize that it significantly reduces radiographic retear rates but does not improve functional outcomes or treatment failure at 2 years — the added cost and iliac crest morbidity are not justified by short-term clinical gains, though longer follow-up may yet reveal benefit from superior structural healing.
First prospective RCT comparing arthroscopic rotator cuff repair with vs. without concentrated bone marrow aspirate (cBMA) augmentation in patients with isolated 1–3 cm supraspinatus tears. Assesses patient-reported outcomes over 2 years and structural integrity on 1-year MRI using Sugaya classification.
When counseling patients on cBMA augmentation for small-to-medium rotator cuff repairs, recognize that it significantly reduces radiographic retear rates but does not improve functional outcomes or treatment failure at 2 years — the added cost and iliac crest morbidity are not justified by short-term clinical gains, though longer follow-up may yet reveal benefit from superior structural healing.